Decarboxylase inhibitor
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SummaryClinical trials on the effect of l-DOPA and decarboxylase inhibitor, Ro 4-4602, in the long-term treatment of Parkinson's…
1. Stride length is highly relevant to mobility and is sensitive to the effects of levodopa in Parkinsonism. Its selection as the…
The effects of combined administration of bombesin and the ornithine decarboxylase (ODC) inhibitor 1,3‐diaminopropane (DAP) on…
We evaluated the effect of administration of L‐dopa, alone or in combination with a peripheral decarboxylase inhibitor, on plasma…
In an open study 25 depressed patients were treated with L-5-hydroxytryptophan (L-5-HTP) either alone or in combination with a…
The gastric anti-ulcer activity of a specific histidine decarboxylase inhibitor naringenin, the aglycone of naringin, a naturally…
Three parkinsonian patients who were nonresponders to levodopa treatment did not improve when shifted to levodopa-decarboxylase…
Carbidopa, a selective extracerebral decarboxylase inhibitor, was given to 10 normal volunteers to determine its effects on…
Concentrations of homovanijlic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the cerebrospinal fluid (CSF) were studied…